Showing results (191-200 of 276) with videos related to

Sort By:
Pageof 28
Vaccine|November 6, 2012
Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®)Troy J Kemp, Mahboobeh Safaeian, Allan Hildesheim, et al.
The New England Journal of Medicine|April 12, 2001
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neckJ Mork, A K Lie, E Glattre, et al.
The Journal of Infectious Diseases|July 1, 1995
Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and SpainB Nonnenmacher, N L Hubbert, R Kirnbauer, et al.
Cancer Immunology, Immunotherapy : CII|March 19, 2009
Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effectTae-Young Lee, Yang-Hyun Kim, Sun-Woo Yoon, et al.
The Journal of General Virology|March 12, 1999
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16H J Bontkes, T D de Gruijl, J M Walboomers, et al.
Mbio|August 7, 2014
Maturation of the human papillomavirus 16 capsidGiovanni Cardone, Adam L Moyer, Naiqian Cheng, et al.
International Journal of Cancer|February 24, 2006
Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in ChinaFarin Kamangar, You-Lin Qiao, John T Schiller, et al.
Plos Pathogens|May 31, 2014
Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomavirusesInci Aydin, Susanne Weber, Berend Snijder, et al.
Cancer|March 20, 1998
A multifaceted study of human papillomavirus and prostate carcinomaH D Strickler, R Burk, K Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor modelH L Greenstone, J D Nieland, K E de Visser, et al.
Pageof 28